BRIDGEWAY CAPITAL MANAGEMENT, LLC - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 29 filers reported holding HISTOGENICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q3 2018$82,000
-78.1%
150,0000.0%0.00%
-75.0%
Q2 2018$375,000
-9.2%
150,0000.0%0.00%0.0%
Q1 2018$413,000
+34.1%
150,0000.0%0.00%
+33.3%
Q4 2017$308,000
+3.7%
150,0000.0%0.00%0.0%
Q3 2017$297,000
+10.0%
150,0000.0%0.00%0.0%
Q2 2017$270,000150,0000.00%
Other shareholders
HISTOGENICS CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Sofinnova Management VIII, L.L.C. 2,077,040$3,593,0001.90%
Abingworth LLP 888,889$1,476,0001.10%
Third Security, LLC 2,690,570$4,655,0000.27%
Perceptive Advisors 1,777,777$3,075,0000.18%
CARL DOMINO INC 89,400$155,0000.17%
SABBY MANAGEMENT, LLC 1,095,422$1,895,0000.10%
Palo Alto Investors LP 302,922$524,0000.02%
THOMPSON DAVIS & CO., INC. 4,500$8,0000.01%
PURA VIDA INVESTMENTS, LLC 13,526$23,0000.01%
Mount Lucas Management LP 14,000$24,0000.01%
View complete list of HISTOGENICS CORP shareholders